|
|
| MRD / Regn No. |
: 20180000952 |
Date |
: 22/07/2026 |
| Patient Name |
: Anjali Gajendran |
Age & Gender |
: 47 Yrs. / Female |
| Contact No. |
: 9841647487 |
UHID |
: |
| Ht / Wt / BMI |
: 148.5 / 57.3 / 25.98 |
BP S / BP D |
: 128 / 81 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (01/Jan/2012) | NAFLD (21/Jun/2021) | DYSLIPIDEMIA (08/Jun/2022) | |
|
Subjective |
: |
LOST TO FOLLOW UP |
|
Objective |
: |
7 KG WEIGHT LOSS,OFF INSULIN |
|
Analysis |
: |
NAFLD F1 S3,TYPE 2 DM,DYSLIPIDEMIA |
|
Plan |
: |
GET ADDITIONAL TESTING,START INSULIN |
|
| Salient Investigations |
: |
HEMOGLOBIN: 9.5 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 90.2 fL | PLATELETS: 296 thou cells/ ul | WBC WHITE BLOOD CELLS: 830 K/uL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 12.6 % | CREATININE: 0.6 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 114.77 mL/min/1.73m2 | UREA: 24 mg/dL | URIC ACID: 2.8 | ALBUMIN (SERUM): 4 g/dL | ALKALINE PHOSPHOTASE: 81 IU/L | DIRECT BILIRUBIN: 0.3 mg/dl | SGOT (AST): 9 U/L | SGPT (ALT): 13 IU/L | FIB4: 0.40 | TOTAL BILIRUBIN: 0.6 mg/dL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
CHOLECALCIFEROL 2000 IU
D RISE 2000 IU |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| TAKE AT BEDTIME | |
|
2 |
ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE FATIGUE AND MUSCLE PAIN | |
|
3 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
12-0-8 UNITS |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 21/Aug/2026 |
| Tests Suggested For Next Visit |
: ABI FUNDUS PHOTOGRAPH,URINE MICROALBUMIN,LIPID PROFILE |
| |
|
| |
|
